This website uses cookies. By continuing you are agreeing to our privacy policy.

Dennis Adeegbe, Ph.D.

Dennis Adeegbe
H. Lee Moffitt Cancer Center & Research Institute
Boosting Immune Activity in the Fight Against Non-Small Cell Lung Cancer
Lung Cancer Discovery Award
Martha Bogdan/ American Lung Association Lung Cancer Discovery Award

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths in the United States, and there is a lack of effective treatments for this disease. We recently found that a drug called ACY241, when administered in an animal model of NSCLC, promoted positive changes in the immune cells within the tumors. We will study how this drug evokes these changes in immune cells and determine if leveraging its immune-enhancing activity will be more effective than existing treatments when combined with other drugs that impair the activity of immune-suppressing T cells. This research could lead to new strategies to combat lung cancer.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.

 

Breathe Easy

Give today and your tax-deductible gift will go TWICE as far for everyone who struggles to breathe.